Faculty profile

Emily Rimmer

ResearcherInternal MedicineUniversity of Manitoba

This profile is built from public research funding records (CIHR, NSERC and SSHRC) and PubMed. We have not imported them from a University of Manitoba directory, so their courses and email address may be missing. Find their university profile.

Emily Rimmer

Researcher

Internal Medicine

Health Sciences

University of Manitoba

Winnipeg, Manitoba, Canada

Supervision signals

Has led research grants, which requires an independent research appointment. Ask their department whether they supervise graduate students.
8 publications in the last five years, latest in 2026.
Senior (last) author on 1 recent paper, a sign of leading a research group.
Principal investigator on 2 research grants (2 CIHR), most recently in 2022.

These signals come from public records, including CIHR, NSERC and SSHRC funding decisions. Ask the professor or the graduate program whether they are taking new students.

Academic metrics

Publications

378

Citations

h-index

Collaborators

Grants

Publications by year

Counts cover the works listed on the university profile; citation counts come from Dimensions.

Profiles and links

Search on Google Scholar

Find them onX · LinkedIn · Bluesky · YouTube

Signals and details

Research

Critical Care Sepsis Septic Shock Therapeutic Apheresis

Latest papers

Analysis of real-world safety, tolerability, and cost efficiency of Sub-Cutaneous administration of Daratumumab in Manitoba.
Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners · 2026 · senior author
Real-World Safety and Tolerability of Rapid, 30-Minutes, Intravenous Isatuximab in Patients With Multiple Myeloma.
Clinical lymphoma, myeloma & leukemia · 2025
Red blood cell transfusion and the use of intravenous iron in iron-deficient patients presenting to the emergency department.
EJHaem · 2025

All 22 publications

Latest funding

Therapeutic Plasma Exchange in Septic Shock (PLEXSIS): A Pilot Study
CIHR · 2022 · Nominated PI
$307,530
Therapeutic Plasma Exchange in Septic Shock: A Pilot Study
CIHR · 2020 · Nominated PI
$100,000

All 2 grants and awards

22 publications.

Analysis of real-world safety, tolerability, and cost efficiency of Sub-Cutaneous administration of Daratumumab in Manitoba.

Quinlan K, Geirnaert M, Kotb R, Dao V, Minuk L, Kasian J, Rimmer E

Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners2026Senior author

DOI: 10.1177/10781552241306741 PMID: 39763381

Real-World Safety and Tolerability of Rapid, 30-Minutes, Intravenous Isatuximab in Patients With Multiple Myeloma.

Kotb R, Geirnaert M, Rimmer E, Dao V, Kasian J, Minuk L, Landego I

Clinical lymphoma, myeloma & leukemia2025

DOI: 10.1016/j.clml.2025.01.022 PMID: 40000356

Red blood cell transfusion and the use of intravenous iron in iron-deficient patients presenting to the emergency department.

Thomas K, Barghi A, Balshaw R, Rimmer E, Leeies M, Houston DS, Garland A, Zarychanski R, Houston BL

EJHaem2025

DOI: 10.1002/jha2.1061 PMID: 39866938

The association of antiplatelet agents with mortality among patients with non-COVID-19 community-acquired pneumonia: a systematic review and meta-analysis.

Lother SA, Tennenhouse L, Rabbani R, Abou-Setta AM, Askin N, Turgeon AF, Murthy S, Houston BL, Houston DS, Mendelson AA, Paul JD, Farkouh ME, Hasmatali J, Rush B, Nkosi J, Goligher EC, Rimmer E, Marshall JC, Shaw SY, Lawler PR, Keynan Y, Zarychanski R

Research and practice in thrombosis and haemostasis2024

DOI: 10.1016/j.rpth.2024.102526 PMID: 39262648

Supportive care strategies in myelodysplastic syndromes and acute myeloid leukemia in older adults: a national survey of Canadian hematologists.

Blankstein AR, Choi N, Mozessohn L, Sanford D, Paulson K, Rimmer E, Houston DS, Lother SA, Mendelson A, Garland A, Zarychanski R, Hay AE, Buckstein R, Houston BL

Annals of hematology2024

DOI: 10.1007/s00277-024-06085-0 PMID: 39562360

Acquired haemophilia A: A 15-year population-based review of incidence rate, patient demographics and treatment outcomes.

Tian C, Perija B, Kotb R, Houston BL, Israels SJ, Houston DS, Rimmer E, Zarychanski R

Haemophilia : the official journal of the World Federation of Hemophilia2023

DOI: 10.1111/hae.14845 PMID: 37639377

White blood cell count trajectory and mortality in septic shock: a historical cohort study.

Rimmer E, Garland A, Kumar A, Doucette S, Houston BL, Menard CE, Leeies M, Turgeon AF, Mahmud S, Houston DS, Zarychanski R

Canadian journal of anaesthesia = Journal canadien d'anesthesie2022First author

DOI: 10.1007/s12630-022-02282-5 PMID: 35902458

Development and internal validation of a clinical prediction model for the diagnosis of immune thrombocytopenia

Li N, Mahamad S, Parpia S, Iorio A, Foroutan F, Heddle NM, Hsia CC, Sholzberg M, Rimmer E, Shivakumar S

Journal of Thrombosis and Haemostasis20229 citations

DOI: 10.1111/jth.15885

Correction to: Intravenous immune globulin in septic shock: a Canadian national survey of critical care medicine and infectious disease specialist physicians.

Leeies M, Gershengorn HB, Charbonney E, Kumar A, Fergusson D, Turgeon AF, Cowan J, Paunovic B, Embil J, Houston DS, Houston B, Rimmer E, Siddiqui F, Cameron B, Murthy S, Marshall JC, Fowler R, Zarychanski R

Canadian journal of anaesthesia = Journal canadien d'anesthesie2021

DOI: 10.1007/s12630-021-01964-w PMID: 33694127

Epidemiology of intravenous immune globulin in septic shock: a retrospective cohort analysis of the Premier Healthcare Database.

Leeies M, Gershengorn HB, Charbonney E, Kumar A, Fergusson DA, Turgeon AF, Garland A, Houston DS, Houston B, Rimmer E, Jacobsohn E, Murthy S, Fowler R, Balshaw R, Zarychanski R

Canadian journal of anaesthesia = Journal canadien d'anesthesie2021

DOI: 10.1007/s12630-021-02081-4 PMID: 34378167

Something wrong or missing on this profile? Suggest a correction

Emily Rimmer

Research

Latest papers

Latest funding

Analysis of real-world safety, tolerability, and cost efficiency of Sub-Cutaneous administration of Daratumumab in Manitoba.

Real-World Safety and Tolerability of Rapid, 30-Minutes, Intravenous Isatuximab in Patients With Multiple Myeloma.

Red blood cell transfusion and the use of intravenous iron in iron-deficient patients presenting to the emergency department.

The association of antiplatelet agents with mortality among patients with non-COVID-19 community-acquired pneumonia: a systematic review and meta-analysis.

Supportive care strategies in myelodysplastic syndromes and acute myeloid leukemia in older adults: a national survey of Canadian hematologists.

Acquired haemophilia A: A 15-year population-based review of incidence rate, patient demographics and treatment outcomes.

White blood cell count trajectory and mortality in septic shock: a historical cohort study.

Development and internal validation of a clinical prediction model for the diagnosis of immune thrombocytopenia

Correction to: Intravenous immune globulin in septic shock: a Canadian national survey of critical care medicine and infectious disease specialist physicians.

Epidemiology of intravenous immune globulin in septic shock: a retrospective cohort analysis of the Premier Healthcare Database.

Therapeutic Plasma Exchange in Septic Shock (PLEXSIS): A Pilot Study

Therapeutic Plasma Exchange in Septic Shock: A Pilot Study

Frequent collaborators

Ryan Zarychanski

Anand Kumar

Murdoch Leeies

Srinivas Murthy

Alan Tinmouth

Eric Bohm

Juthaporn Cowan

Ryan Zarychanski

Dean Fergusson

Deborah Cook

Yoav Keynan

Lee Mozessohn

Caroline Hamm

Asher Mendelson

Na Li

Salmaan Kanji

Ryan Zarychanski

Nancy Heddle

Mohammad Refaei

Sameer Parpia

Alexis Turgeon

Sudeep Shivakumar

Lauralyn McIntyre

Alfonso Iorio

Farid Foroutan

Donald Arnold

Alison Fox-Robichaud

Na Li